Cargando…
Who continues to stock oral artemisinin monotherapy? Results of a provider survey in Myanmar
BACKGROUND: Artemisinin-based combination therapy (ACT) is a key strategy for global malaria elimination efforts. However, the development of artemisinin-resistant malaria parasites threatens progress and continued usage of oral artemisinin monotherapies (AMT) predisposes the selection of drug resis...
Autores principales: | Thein, Si Thu, Sudhinaraset, May, Khin, Hnin Su Su, McFarland, Willi, Aung, Tin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918101/ https://www.ncbi.nlm.nih.gov/pubmed/27333781 http://dx.doi.org/10.1186/s12936-016-1392-5 |
Ejemplares similares
-
Insights into the availability and distribution of oral artemisinin monotherapy in Myanmar: evidence from a nationally representative outlet survey
por: Thein, Si Thu, et al.
Publicado: (2017) -
Oral artemisinin monotherapy removal from the private sector in Eastern Myanmar between 2012 and 2014
por: Khin, Hnin Su Su, et al.
Publicado: (2016) -
Improving uptake and use of malaria rapid diagnostic tests in the context of artemisinin drug resistance containment in eastern Myanmar: an evaluation of incentive schemes among informal private healthcare providers
por: Aung, Tin, et al.
Publicado: (2015) -
Using supply side evidence to inform oral artemisinin monotherapy replacement in Myanmar: a case study
por: Khin, Hnin Su Su, et al.
Publicado: (2016) -
Availability and quality of anti-malarials among private sector outlets in Myanmar in 2012: results from a large, community-based, cross-sectional survey before a large-scale intervention
por: Khin, Hnin Su Su, et al.
Publicado: (2015)